Curis, Inc. (CRIS) vs Trevena, Inc. (TRVN)
Curis, Inc. and Trevena, Inc. are both Biotechnology companies. Curis, Inc. and Trevena, Inc. are of similar size ($1.8M and $1.8M). Curis, Inc. grew revenue faster over the last twelve months: −13.4% against −83.0%. Curis, Inc. has the higher net margin (0.00% vs −6,233.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Curis, Inc. leads on 12 and Trevena, Inc. on 4.
Valuation
Profitability
| Metric | CRIS | TRVN | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.52% | (190.29%) | 65.16% |
| Operating margin | 0.00% | (5,879.85%) | 0.00% |
| Net margin | 0.00% | (6,233.70%) | 0.00% |
| Free cash flow margin | 0.00% | (4,961.72%) | 0.00% |
| Return on equity | 455.35% | 344.49% | (57.72%) |
| Return on assets | (87.76%) | (105.83%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack